IP Library › Assignment 055657/0319
Patent Assignment
Reel/Frame 055657/0319

Assignment of Assignor's Interest

Recorded: 2021-03-19 Pages: 11
Assignor
MCLAUGHLIN, TRACEY L.
Executed: 2011-09-24
Assignee
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
BUILDING 170, 3RD FLOOR, MAIN QUAD P.O. BOX 20386, OFFICE OF THE GENERAL COUNSEL, STANFORD, CALIFORNIA, 94305
Covered Properties (3)
Buffered Formulations Of Exendin (9-39)
Application: 16/461,329 →
Publication: US 2020/0069802
Buffered Formulations of Exendin (9-39)
Application: 62/424,979 →
Buffered Formulations of Exendin (9-39)
Application: 62/517,065 →
Related Assignments (9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 22, 2016
From: XIONG, XIAOFENG; ODINK, DEBRA
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 040756/0170 →
Assignment of Assignor's Interest Nov 13, 2017
From: SMITH, CHRISTINE M. N.
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 044113/0141 →
Assignment of Assignor's Interest Nov 14, 2017
From: XIONG, XIAOFENG; ODINK, DEBRA; SMITH, CHRISTINE M. N.
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 044124/0581 →
Assignment of Assignor's Interest Nov 20, 2017
From: CRAIG, COLLEEN M.
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 044182/0417 →
Assignment of Assignor's Interest Nov 20, 2017
From: CRAIG, COLLEEN M.
To: EIGER BIOPHARMACEUTICALS, INC.; THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 044182/0464 →
Assignment of Assignor's Interest May 3, 2021
From: XIONG, XIAOFENG; ODINK, DEBRA; SMITH, CHRISTINE M.N.; CRAIG, COLLEEN M.
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 056120/0084 →
Security Interest Jun 10, 2022
From: EIGER BIOPHARMACEUTICALS, INC.; EB PHARMA, LLC; EBPI MERGER, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 060156/0901 →
Assignment of Assignor's Interest Aug 14, 2024
From: EIGER BIOPHARMACEUTICALS, INC.
To: AMYLYX PHARMACEUTICALS, INC.
Reel/Frame 068283/0933 →
Assignment of Assignor's Interest Sep 24, 2024
From: EIGER BIOPHARMACEUTICALS, INC.
To: AMYLYX PHARMACEUTICALS, INC.
Reel/Frame 068683/0015 →